163 related articles for article (PubMed ID: 8568018)
1. Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Tsutsumi K; Fujii I; Takeyama M
J Clin Pharmacol; 1995 Oct; 35(10):995-1002. PubMed ID: 8568018
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of unbound serum carbamazepine and carbamazepine-10,11-epoxide concentration prediction methods in polytherapy adult patients with epilepsy.
Kodama Y; Kuranari M; Fujii I; Kodama H; Takeyama M
Am J Ther; 1996 Oct; 3(10):699-707. PubMed ID: 11862225
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of equations for unbound serum concentration prediction of carbamazepine and carbamazepine-10,11-epoxide in polytherapy pediatric patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Fujii I; Takeyama M
J Pharm Sci; 1995 Jul; 84(7):835-9. PubMed ID: 7562433
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of binding equation method for prediction of unbound serum valproic acid concentration in pediatric patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Koike Y; Yasunaga F; Fujii I; Takeyama M
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):114-8. PubMed ID: 7757310
[TBL] [Abstract][Full Text] [Related]
5. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
Svinarov DA; Pippenger CE
Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
[TBL] [Abstract][Full Text] [Related]
6. In vivo binding characteristics of carbamazepine and carbamazepine-10,11-epoxide to serum proteins in paediatric patients with epilepsy.
Kodama Y; Tsutsumi K; Kuranari M; Kodama H; Fujii I; Takeyama M
Eur J Clin Pharmacol; 1993; 44(3):291-3. PubMed ID: 8491247
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two binding equations for prediction of the concentration of unbound valproic acid in the serum of adult epileptic polytherapy patients.
Kodama Y; Kuranari M; Kodama H; Zaizen T; Yukawa E; Fujii I; Takeyama M
J Pharm Pharmacol; 1996 Oct; 48(10):1068-72. PubMed ID: 8953510
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Binding Equation Method for Unbound Serum Concentration Prediction of Valproic Acid in Polytherapy Pediatric Patients with Epilepsy.
Kodama Y; Kuranari M; Kodama H; Ashikari Y; Fujii I; Takeyama M
Am J Ther; 1995 Feb; 2(2):106-111. PubMed ID: 11847536
[TBL] [Abstract][Full Text] [Related]
9. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
Carlsson KC; Hoem NO; Glauser T; Vinks AA
Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
[TBL] [Abstract][Full Text] [Related]
10. Total and free serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in children with epilepsy.
Agbato OA; Elyas AA; Patsalos PN; Brett EM; Lascelles PT
Arch Neurol; 1986 Nov; 43(11):1111-6. PubMed ID: 3778243
[TBL] [Abstract][Full Text] [Related]
11. Prediction of unbound serum valproic acid concentration by using in vivo binding parameters.
Kodama Y; Kuranari M; Tsutsumi K; Kimoto H; Fujii I; Takeyama M
Ther Drug Monit; 1992 Oct; 14(5):349-53. PubMed ID: 1448839
[TBL] [Abstract][Full Text] [Related]
12. In vivo determinations of carbamazepine and carbamazepine-10, 11-epoxide binding parameters to serum proteins in monotherapy patients.
Kodama Y; Kuranari M; Kodama H; Fujii I; Takeyama M
J Clin Pharmacol; 1993 Sep; 33(9):851-5. PubMed ID: 8227483
[TBL] [Abstract][Full Text] [Related]
13. Protein binding of carbamazepine and its epoxide in maternal and fetal plasma at delivery: comparison to other anticonvulsants.
Kuhnz W; Steldinger R; Nau H
Dev Pharmacol Ther; 1984; 7(1):61-72. PubMed ID: 6697871
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing simultaneous concentrations of total and free carbamazepine and carbamazepine-10, 11-epoxide in serum of children with epilepsy.
Elyas AA; Patsalos PN; Agbato OA; Brett EM; Lascelles PT
Ther Drug Monit; 1986; 8(3):288-92. PubMed ID: 3750372
[TBL] [Abstract][Full Text] [Related]
15. Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy.
Contin M; Riva R; Albani F; Perucca E; Lamontanara G; Baruzzi A
Eur J Clin Pharmacol; 1985; 29(2):211-4. PubMed ID: 4076320
[TBL] [Abstract][Full Text] [Related]
16. In vivo binding characteristics of carbamazepine and carbamazepine 10, 11-epoxide to serum proteins in monotherapy adult patients.
Kodama Y; Kuranari M; Tsutsumi K; Okamoto T; Kodama H; Yasunaga F; Fujii I; Takeyama M
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):618-21. PubMed ID: 7874378
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
18. Predictive capacity of carbamazepine pharmacokinetic parameters in a Portuguese outpatient population.
Falcão AC; de Almeida AM; Leitão F; Santos J; Sales F; Caramona MM
Ther Drug Monit; 1999 Apr; 21(2):224-30. PubMed ID: 10217344
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for carbamazepine elevation and toxicity following epilepsy surgery.
Hiremath GK; Kotagal P; Bingaman W; Hovinga C; Wyllie E; Morris H; Nelson D
Seizure; 2005 Jul; 14(5):312-7. PubMed ID: 15876544
[TBL] [Abstract][Full Text] [Related]
20. No increase in carbamazepine-10,11-epoxide during addition of lamotrigine treatment in children.
Eriksson AS; Boreus LO
Ther Drug Monit; 1997 Oct; 19(5):499-501. PubMed ID: 9357090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
